| Code | Description | Claims | Beneficiaries | Total Paid |
| A0425 |
Ground mileage, per statute mile |
27 |
25 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
167 |
130 |
$9K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
234 |
167 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
75 |
58 |
$4K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12 |
12 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27 |
24 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
60 |
49 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$575.58 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
38 |
37 |
$557.60 |
| A9270 |
Non-covered item or service |
79 |
38 |
$0.00 |